Evidence map›Paper›PMID 28915559›Full record

ArticleOncotarget2017

Zbtb1 controls NKp46

Ying Lu, Xianyu Zhang, Nicolas Bouladoux, Saransh Neel Kaul, Kangxin Jin, Derek Sant'Angelo, Yasmine Belkaid, Damian Kovalovsky

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. ILC3: a case of conflicted identity.Frontiers in immunology · 2023
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Ying LuExperimental Immunology Branch, NCI, NIH, Bethesda, MD, USA.
Xianyu ZhangExperimental Immunology Branch, NCI, NIH, Bethesda, MD, USA.
Nicolas BouladouxMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD, USA.
Saransh Neel KaulUniversity of Maryland, College Park, MD, USA.
Kangxin JinZhongshan Ophthalmic Center, State Key Laboratory for Ophthalmic Researches, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Derek Sant'AngeloCancer Metabolism and Growth Program, Rutgers, Child Health Institute of New Jersey, New Brunswick, NJ, USA.
Yasmine BelkaidMucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD, USA.
Damian KovalovskyExperimental Immunology Branch, NCI, NIH, Bethesda, MD, USA.
National Institutes of Health · USNational Institute of Allergy and Infectious Diseases · USRutgers, The State University of New Jersey · USSun Yat-sen University · CNUniversity of Maryland, College Park · US

Funding

Role of Tissue-Specific Factors in the Control of ImmunityZIAAI001132 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BELKAID, YASMINE · 2011 to 2025
$6.4M
Zbtb family members in lymphocyte differentiation and functionZIABC011429 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KOVALOVSKY, DAMIAN · 2012 to 2017
$3.4M
Intramural NIH HHS ZIA BC011429
6 · The paper itself

Abstract

Innate lymphoid cells (ILCs) play a central role conferring protection at the mucosal frontier. In this study, we have identified a requirement of the transcription factor Zbtb1 for the development of RORγt

Indexed as

IFN-γILCILC3Immune responseImmunityImmunology and Microbiology Sectioninnate lymphoid cellsZbtb1

Identifiers

PMID28915559
PMCPMC5593530
OpenAlexW2740064111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.